ArticleIntegrative cancer therapies2018
Integrative Oncology in Supportive Cancer Care in Israel.
Article in Integrative cancer therapies, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Integrative oncology in clinical practice, research, and education: Middle-Eastern and global perspectives.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Review
- Integrative oncology: evolution, framework, and future directions.Frontiers in oncology · 2026Article
- Educating healthcare professionals on interprofessional counseling in integrative oncology: development and evaluation protocol of the blended-learning program INSIGHT.Frontiers in medicine · 2026Article
- Acupuncture in obstetrics: delivery room integrative medicine for anxiety and pain.BMJ supportive & palliative care · 2025Article
- From supportive care to trauma: training integrative practitioners in the treatment of acute stress disorder.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024Article
- Traditional and Complementary Medicine Use among Cancer Patients in Asian Countries: A Systematic Review and Meta-Analysis.Cancers · 2024Review
- Impact of Systematic Holistic Nursing Combined with Narrative Nursing Intervention for Patients with Advanced Gastric Cancer on Complications and Negative Emotions.Evidence-based complementary and alternative medicine : eCAM · 2022Article
- Exploring Herbal Medicine Use during Palliative Cancer Care: The Integrative Physician as a Facilitator of Pharmacist-Patient-Oncologist Communication.Pharmaceuticals (Basel, Switzerland) · 2020Review
- Pancreatic Cancer (PDAC): Introduction of Evidence-Based Complementary Measures into Integrative Clinical Management.Cancers · 2020Review
- Complementary and Integrative Medicine Use in Individuals Seeking Conventional Medical Oncology Care in Chile: Prevalence and Patient Characteristics.Journal of global oncology · 2019Article
- Integrative Oncology: An International Perspective from Six Countries.Integrative cancer therapiesArticle
- Integrative OncologyIntegrative cancer therapiesArticle
- Adherence to Integrative Care, Oncology Healthcare Utilization, Opioid Use and Hospitalization.Integrative cancer therapiesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeIntegrative oncology (IO) services provide complementary/integrative medicine (CIM) therapies to patients as part of their supportive cancer care. In this study, we examine and compare the structural, operational, financial and academic/research-related aspects of IO services in Israeli oncology centers.
methodsThe medical directors of seven Israeli IO programs completed questionnaires which explored the objectives and organizational features of their service within the context of supportive cancer care.
resultsAll participating IO services addressed patient-reported concerns related to quality of life and function, within the context of conventional supportive cancer care. The centers shared similar characteristics regarding the procedure of referral to their service and emphasized research and teaching initiatives within an academic framework, as part of their clinical practice. A number of obstacles to integration were identified, primarily those related to financial considerations, such as the need for patients to carry the cost of the CIM treatments.
conclusionsIO services situated within conventional oncology departments in Israel share a number of characteristics, as well as obstacles to their incorporation into standard care. All participating centers described both clinical and academic activities, including research initiatives and the promotion of CIM in an academic setting. Further research is needed in order to better understand the place of CIM in the oncology setting and prioritize the allocation of resources in order to advance the inclusion of CIM in standard supportive cancer care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.